A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

Clinical trial NCT01074008 · COMPLETED

Trial details

NCT number: NCT01074008
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C HCV Chronic Hepatitis C Infection Hepatitis C Genotype 1

Start date: 2010-03-01
Primary completion: 2011-06-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.